Literature DB >> 20215985

Muscle-Eye-Brain disease.

Anant M Shenoy1, Jennifer A Markowitz, Carsten G Bonnemann, Kalpathy Krishnamoorthy, Aaron D Bossler, Brian S Tseng.   

Abstract

A term female infant was evaluated for global developmental delay, hypotonia, hyporeflexia, diffuse weakness including facial muscles, and visual impairment with optic nerve hypoplasia. In the absence of family history or perinatal concerns, an extensive investigation was performed, including lab studies, muscle biopsy, brain MRI and focused genetic testing. This revealed elevated serum CK, a structurally abnormal brain, and a dystrophic-appearing muscle biopsy with evidence of a glycosylation defect in the alpha-dystroglycan complex. Of the 6 known related genes, testing of the POMGnT1 gene showed three heterozygous missense mutations. Thus her history, examination, biopsy specimen, imaging, laboratory, and genetic studies are all consistent with the diagnosis of Muscle-Eye-Brain (MEB) disease. MEB is one of an emerging spectrum of congenital disorders that involve both central and peripheral nervous systems, described further in this case report.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215985      PMCID: PMC2925645          DOI: 10.1097/CND.0b013e3181c5054d

Source DB:  PubMed          Journal:  J Clin Neuromuscul Dis        ISSN: 1522-0443


  9 in total

1.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix.

Authors:  O Ibraghimov-Beskrovnaya; J M Ervasti; C J Leveille; C A Slaughter; S W Sernett; K P Campbell
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

2.  Limb-girdle muscular dystrophy in the United States.

Authors:  Steven A Moore; Christopher J Shilling; Steven Westra; Cheryl Wall; Matthew P Wicklund; Catherine Stolle; Charlotte A Brown; Daniel E Michele; Federica Piccolo; Thomas L Winder; Aaron Stence; Rita Barresi; Nick King; Wendy King; Julaine Florence; Kevin P Campbell; Gerald M Fenichel; Hansell H Stedman; John T Kissel; Robert C Griggs; Shree Pandya; Katherine D Mathews; Alan Pestronk; Carmen Serrano; Daniel Darvish; Jerry R Mendell
Journal:  J Neuropathol Exp Neurol       Date:  2006-10       Impact factor: 3.685

3.  Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.

Authors:  E Mercuri; S Messina; C Bruno; M Mora; E Pegoraro; G P Comi; A D'Amico; C Aiello; R Biancheri; A Berardinelli; P Boffi; D Cassandrini; A Laverda; M Moggio; L Morandi; I Moroni; M Pane; R Pezzani; A Pichiecchio; A Pini; C Minetti; T Mongini; E Mottarelli; E Ricci; A Ruggieri; S Saredi; C Scuderi; A Tessa; A Toscano; G Tortorella; C P Trevisan; C Uggetti; G Vasco; F M Santorelli; E Bertini
Journal:  Neurology       Date:  2009-03-18       Impact factor: 9.910

4.  Diagnosis and etiology of congenital muscular dystrophy.

Authors:  R A Peat; J M Smith; A G Compton; N L Baker; R A Pace; D J Burkin; S J Kaufman; S R Lamandé; K N North
Journal:  Neurology       Date:  2007-12-26       Impact factor: 9.910

5.  POMGnT1 gene alterations in a family with neurological abnormalities.

Authors:  Virginie S Vervoort; Kenton R Holden; Kennedy C Ukadike; Julianne S Collins; Robert A Saul; Anand K Srivastava
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

Review 6.  Muscular dystrophies due to glycosylation defects.

Authors:  Francesco Muntoni; Silvia Torelli; Martin Brockington
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 7.  Muscular dystrophies due to defective glycosylation of dystroglycan.

Authors:  F Muntoni; M Brockington; C Godfrey; M Ackroyd; S Robb; A Manzur; M Kinali; E Mercuri; M Kaluarachchi; L Feng; C Jimenez-Mallebrera; E Clement; S Torelli; C A Sewry; S C Brown
Journal:  Acta Myol       Date:  2007-12

8.  A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.

Authors:  Cecilia Jimenez-Mallebrera; Silvia Torelli; Lucy Feng; Jihee Kim; Caroline Godfrey; Emma Clement; Rachael Mein; Stephen Abbs; Susan C Brown; Kevin P Campbell; Stephan Kröger; Beril Talim; Haluk Topaloglu; Ros Quinlivan; Helen Roper; Anne M Childs; Maria Kinali; Caroline A Sewry; Francesco Muntoni
Journal:  Brain Pathol       Date:  2008-08-07       Impact factor: 6.508

9.  Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.

Authors:  Caroline Godfrey; Emma Clement; Rachael Mein; Martin Brockington; Janine Smith; Beril Talim; Volker Straub; Stephanie Robb; Ros Quinlivan; Lucy Feng; Cecilia Jimenez-Mallebrera; Eugenio Mercuri; Adnan Y Manzur; Maria Kinali; Silvia Torelli; Susan C Brown; Caroline A Sewry; Kate Bushby; Haluk Topaloglu; Kathryn North; Stephen Abbs; Francesco Muntoni
Journal:  Brain       Date:  2007-09-18       Impact factor: 13.501

  9 in total
  2 in total

1.  Macular optical coherence tomography in patients with unilateral optic nerve hypoplasia.

Authors:  Javaneh Abbasian; Norman Blair; Mahnaz Shahidi; Gui-Shuaung Ying; Jiayan Huang; Lawrence Kaufman; Michael Blair
Journal:  J AAPOS       Date:  2015-02       Impact factor: 1.220

2.  Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.

Authors:  Josef Voglmeir; Sara Kaloo; Nicolas Laurent; Marco M Meloni; Lisa Bohlmann; Iain B H Wilson; Sabine L Flitsch
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.